Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > POS

<< Previous

Bullboard Posts

Next >>

Comment by sweenbyon Jul 27, 2010 1:04am

337 Views

Post# 17298855

RE: POS

Linda never pumped this at all. The properties are still here large as life. Reverse the stock float and you got it made.They have gone through some tough times in the venture market or have you missed all of that. The quicker you guys move on the better. Just remember they will eat you up like chopped liver.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec